CGON   $67.7  2.16% Market Closed After Close 67.6 -0.15%

CG Oncology, Inc.
Total Cash 552.88M
totalCashPerShare 8.242
EBITDA -68.18M
Total Debt 355.00K
quickRatio 56.757
currentRatio 57.954
Total Revenue 539.00K
debtToEquity 0.064
Revenue/Share 0.036
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -63.70M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -232.9099
profitMargins 0.0
enterpriseValue 1.86B
forwardPE -20.174158
floatShares 44.67M
sharesOutstanding 67.08M
sharesShort 5.96M
sharesShortPriorMonth 6.06M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.80%
Short Ratio help_outline 6.06%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 8.286
Price To Book help_outline 4.33
earningsQuarterlyGrowth
netIncomeToCommon -72.33M
trailingEps -1.14%
forwardEps -1.78%
enterpriseToEbitda -27.23
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.37 3Q 2024
institutionsCount 169
lastUpdated Nov. 2, 2024, 7:04 a.m.